Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I evaluation of the effects of ketoconazole and rifampicin on cediranib pharmacokinetics in patients with solid tumours.
Lassen U, Miller WH, Hotte S, Evans TR, Kollmansberger C, Adamson D, Nielsen DL, Spicer J, Chen E, Meyer T, Brown K, Rafi R, Sawyer MB. Lassen U, et al. Among authors: rafi r. Cancer Chemother Pharmacol. 2013 Feb;71(2):543-9. doi: 10.1007/s00280-012-2038-0. Epub 2012 Nov 30. Cancer Chemother Pharmacol. 2013. PMID: 23196640 Clinical Trial.
Ninth Annual DC Public Health Case Challenge: Protective Community Environments and Their Contribution to Intimate Partner Violence Prevention: The Role of Youth.
Geller A, Baciu A, Anderson M, Abu-Hijlih M, Altaher N, Authelet K, Avelar B, Baran E, Brenner A, Chace A, Curley M, Faulkner R, Hoffman C, Holland J, Jhaveri U, Jones M, Kim HE, Krekorian C, LeBuhn H, Ly E, Mata E, Miloh R, Naumova A, Parsons A, Pappier G, Patriarca PN, Pierson B, Rafi R, Raghavan P, Rice C, Santacrose L, Sheehi K, Singh A, Smith B, Smith L, Tandy H. Geller A, et al. Among authors: rafi r. NAM Perspect. 2023 Sep 6;2023:10.31478/202309a. doi: 10.31478/202309a. eCollection 2023. NAM Perspect. 2023. PMID: 38812842 Free PMC article. Review. No abstract available.
Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial.
Smith AG, Singleton JR, Aperghis A, Coffey CS, Creigh P, Cudkowicz M, Conwit R, Ecklund D, Fedler JK, Gudjonsdottir A, Hauer P, Herrmann DN, Kearney M, Kissel J, Klingner E, Quick A, Revere C, Stino A; NeuroNEXT NN108 TopCSPN Study Team. Smith AG, et al. JAMA Neurol. 2023 Dec 1;80(12):1334-1343. doi: 10.1001/jamaneurol.2023.3711. JAMA Neurol. 2023. PMID: 37870862 Clinical Trial.
12 results